Back to Search
Start Over
Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.
- Source :
-
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2018 Feb; Vol. 89 (2), pp. 169-174. Date of Electronic Publication: 2017 Sep 14. - Publication Year :
- 2018
-
Abstract
- Objectives: The onset of parkinsonism in patients with drug-induced parkinsonism (DIP) exhibits extensive individual variability following exposure to offending drugs. We investigated whether the individual variations in the onset time of parkinsonism reflected the underlying subtle dopaminergic dysfunction in DIP.<br />Methods: We enrolled 71 patients with DIP who had visually normal striatal dopamine transporter (DAT) availability in <superscript>18</superscript> F-FP-CIT positron emission tomography scans. According to their exposure durations to the offending drugs prior to onset of the parkinsonism, the patients were divided into the early-onset group (duration ≤6 months; n=35) and delayed-onset group (duration >6 months; n=36). We performed the quantitative analysis of the DAT availability in each striatal subregion between the groups.<br />Results: No patients with DIP had DAT availability that was more than 2 SD below the normal mean of DAT availability. Compared with the delayed-onset group, the early-onset DIP group had decreased DAT availability in the striatal subregions including the posterior putamen (p=0.018), anterior putamen (p=0.011), caudate (p=0.035) and ventral striatum (p=0.027). After adjusting for age, sex and cross-cultural smell identification test scores, a multivariate analysis revealed that the DAT availability in the striatal subregions of the patients with DIP was significantly and positively associated with the natural logarithm of the duration of drug exposure.<br />Conclusions: These results suggest that a short exposure to the offending drugs before the development of parkinsonism would be associated with subtle nigrostriatal dopaminergic dysfunction in patients with DIP.<br />Competing Interests: Competing interests: None declared.<br /> (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
- Subjects :
- Aged
Anticonvulsants adverse effects
Antiemetics adverse effects
Antipsychotic Agents adverse effects
Calcium Channel Blockers adverse effects
Case-Control Studies
Caudate Nucleus diagnostic imaging
Caudate Nucleus metabolism
Corpus Striatum diagnostic imaging
Deprescriptions
Female
Fluorine Radioisotopes
Humans
Male
Middle Aged
Neostriatum diagnostic imaging
Neostriatum metabolism
Parkinsonian Disorders chemically induced
Parkinsonian Disorders diagnostic imaging
Parkinsonian Disorders physiopathology
Positron-Emission Tomography
Putamen diagnostic imaging
Putamen metabolism
Radiopharmaceuticals
Recovery of Function
Selective Serotonin Reuptake Inhibitors adverse effects
Time Factors
Tropanes
Valproic Acid adverse effects
Ventral Striatum diagnostic imaging
Ventral Striatum metabolism
Corpus Striatum metabolism
Dopamine Plasma Membrane Transport Proteins metabolism
Parkinsonian Disorders metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1468-330X
- Volume :
- 89
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of neurology, neurosurgery, and psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 28912301
- Full Text :
- https://doi.org/10.1136/jnnp-2017-315873